Genotypic diversity and antimicrobial resistance phenotype of carbapenem-resistant and carbapenem-susceptible Acinetobacter species isolates
- PMID: 40204623
- DOI: 10.1016/j.pathol.2024.12.647
Genotypic diversity and antimicrobial resistance phenotype of carbapenem-resistant and carbapenem-susceptible Acinetobacter species isolates
Abstract
Members of the Acinetobacter baumannii complex are common nosocomial pathogens with propensity for developing carbapenem resistance. Much emphasis is placed on carbapenem-resistant Acinetobacter baumannii (CRAB), although carbapenem-susceptible Acinetobacter baumannii (CSAB) isolates also cause serious infections. Genomic and phenotypic differences between these isolates are analysed in this study. Whole-genome sequencing was performed on a collection of 90 non-duplicate isolates of Acinetobacter spp. isolates. Phenotypic susceptibility results performed routinely were also collected and correlated against presence of antimicrobial resistance (AMR) genes. The included isolates were predominantly A. baumannii (n=77), followed by Acinetobacter nosocomialis (n=8), Acinetobacter pittii (n=2), Acinetobacter ursingii (n=1), Acinetobacter soli (n=1), and Acinetobacter colistiniresistens (n=1). After excluding duplicate isolates, most of the 77 A. baumannii isolates were identified as carbapenem-resistant sequence type (ST) 2 strains (n=43), which were associated with the presence of oxacillinase (OXA)-23 carbapenemases. Comparatively, CSAB were more diverse, comprising various STs. Overall susceptibilities to non-β-lactam antibiotics indicate highest susceptibility rates to co-trimoxazole, followed by gentamicin and quinolones. Isolates that were resistant to co-trimoxazole possessed sul1 and/or sul2 genes and isolates resistant to gentamicin had armA and/or ant(2″)-Ia genes. CRAB and CSAB were also distinctly different in terms of resistance to non-β-lactam antibiotics with >90% susceptibility to quinolones, co-trimoxazole, and gentamicin in CSAB isolates, compared to 4.2%, 56.3%, and 33.3% in CRAB. Further stratification was performed based on capsular polysaccharide [K locus (KL)] types. The resistance rates amongst the three most common KL types in carbapenem-resistant ST2 isolates showed considerable variation. For gentamicin, 92.9% (13/14) of KL10, 61.5% (8/13) of KL210, and 45.5% (5/11) of KL2 isolates were resistant. For co-trimoxazole, 0.0% (0/14) of KL10, 92.3% (12/13) of KL210, and 36.4% (4/11) of KL2 isolates were resistant. Overall, the most common types were KL10 (n=15), KL210 (n=14), KL2 (n=11), KL24 (n=6), and KL106 (n=5). The most common types seen in blood isolates were KL210 and KL24 (n=4 each). In summary, CRAB in our institution is dominated by ST2 isolates. There was also strong correlation between the AMR genes present with phenotypic resistance in our collection of isolates. KL type provides further stratification of isolates in terms of invasiveness and AMR.
Keywords: Acinetobacter baumannii complex; carbapenem-resistant Acinetobacter baumannii; whole-genome sequencing.
Copyright © 2025 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023.Microbiol Spectr. 2025 Jul;13(7):e0083225. doi: 10.1128/spectrum.00832-25. Epub 2025 Jun 9. Microbiol Spectr. 2025. PMID: 40488459 Free PMC article.
-
In silico and in vitro comparative analysis of 79 Acinetobacter baumannii clinical isolates.Microbiol Spectr. 2025 Jul;13(7):e0284924. doi: 10.1128/spectrum.02849-24. Epub 2025 May 16. Microbiol Spectr. 2025. PMID: 40377313 Free PMC article.
-
Whole genome analysis revealed the role of blaOXA-23 and blaOXA-66 genes in carbapenem resistance of Acinetobacter baumannii strains.Pathog Glob Health. 2025 Feb-Mar;119(1-2):10-21. doi: 10.1080/20477724.2024.2442194. Epub 2024 Dec 19. Pathog Glob Health. 2025. PMID: 39699991
-
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis.Clin Microbiol Infect. 2014 May;20(5):416-23. doi: 10.1111/1469-0691.12363. Epub 2013 Oct 17. Clin Microbiol Infect. 2014. PMID: 24131374
-
A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.Int J Risk Saf Med. 2023;34(4):337-355. doi: 10.3233/JRS-220037. Int J Risk Saf Med. 2023. PMID: 37154184
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous